CAMPHOR, MENTHOL

CAMPHOR, MENTHOL was reported 822 times

These side effects are most commonly reported by patients taking CAMPHOR, MENTHOL:

# Side effect Count
0 DRUG INEFFECTIVE 223
1 NO ADVERSE EVENT 161
2 APPLICATION SITE BURN 57
3 PAIN 46
4 APPLICATION SITE PAIN 38
5 BURNING SENSATION 32
6 BLISTER 30
7 SKIN BURNING SENSATION 27
8 ARTHRALGIA 25
9 PAIN IN EXTREMITY 25
10 APPLICATION SITE ERYTHEMA 24
11 DIARRHOEA 24
12 FATIGUE 23
13 APPLICATION SITE VESICLES 22
14 HEADACHE 22
15 NAUSEA 22
16 THERMAL BURN 22
17 ERYTHEMA 21
18 BACK PAIN 19
19 BURNS SECOND DEGREE 19
20 DIZZINESS 19
21 DYSPNOEA 19
22 CHEMICAL INJURY 18
23 VOMITING 18
24 PRURITUS 17
25 HYPERSENSITIVITY 16
26 OFF LABEL USE 16
27 CONSTIPATION 15
28 FALL 15
29 RASH 15
30 SKIN EXFOLIATION 15
31 CHEMICAL BURN 13
32 INSOMNIA 13
33 PERIPHERAL SWELLING 13
34 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 13
35 PRODUCT QUALITY ISSUE 13
36 PRODUCT USE ISSUE 13
37 URINARY TRACT INFECTION 13
38 GAIT DISTURBANCE 12
39 MALAISE 12
40 SCAR 12
41 NECK PAIN 11
42 PNEUMONIA 11
43 PRODUCT DOSE OMISSION ISSUE 11
44 INFUSION SITE PAIN 10
45 MUSCLE SPASMS 10
46 MYALGIA 10
47 SKIN DISCOLOURATION 10
48 ABDOMINAL PAIN 9
49 BURNS THIRD DEGREE 9
50 DECREASED APPETITE 9
51 FEELING ABNORMAL 9
52 HYPOAESTHESIA 9
53 LOSS OF CONSCIOUSNESS 9
54 SOMNOLENCE 9
55 ASTHENIA 8
56 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8
57 INFECTION 8
58 MUSCULOSKELETAL STIFFNESS 8
59 SCAB 8
60 CONDITION AGGRAVATED 7
61 COUGH 7
62 DEATH 7
63 EXPIRED PRODUCT ADMINISTERED 7
64 MOBILITY DECREASED 7
65 MUSCULOSKELETAL PAIN 7
66 PRODUCT ADHESION ISSUE 7
67 PYREXIA 7
68 SWELLING 7
69 URTICARIA 7
70 WEIGHT DECREASED 7
71 WEIGHT INCREASED 7
72 ABDOMINAL DISCOMFORT 6
73 ANXIETY 6
74 ARTHRITIS 6
75 COVID-19 6
76 DEPRESSION 6
77 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6
78 FEELING HOT 6
79 INFUSION SITE ERYTHEMA 6
80 NASAL CONGESTION 6
81 PRODUCT USE IN UNAPPROVED INDICATION 6
82 SKIN IRRITATION 6
83 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6
84 ALOPECIA 5
85 APPLICATION SITE DISCOLOURATION 5
86 BLOOD PRESSURE DECREASED 5
87 BRONCHITIS 5
88 CHEST PAIN 5
89 CONTUSION 5
90 DISCOMFORT 5
91 DRUG EFFECT LESS THAN EXPECTED 5
92 HYPERAESTHESIA 5
93 HYPOTENSION 5
94 JOINT SWELLING 5
95 LIMB DISCOMFORT 5
96 MEMORY IMPAIRMENT 5
97 MYOCARDIAL INFARCTION 5
98 NASOPHARYNGITIS 5
99 OEDEMA PERIPHERAL 5
100 PAIN OF SKIN 5
101 PRODUCT ODOUR ABNORMAL 5
102 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5
103 THERAPEUTIC RESPONSE DECREASED 5
104 VISION BLURRED 5
105 AMNESIA 4
106 ANAPHYLACTIC REACTION 4
107 APPLICATION SITE EXFOLIATION 4
108 APPLICATION SITE PRURITUS 4
109 APPLICATION SITE SWELLING 4
110 BALANCE DISORDER 4
111 BONE PAIN 4
112 CHEMICAL BURN OF SKIN 4
113 DEVICE OCCLUSION 4
114 DRUG INTERACTION 4
115 EYE PAIN 4
116 HERPES ZOSTER 4
117 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4
118 INFUSION SITE HAEMORRHAGE 4
119 INFUSION SITE PRURITUS 4
120 INFUSION SITE SWELLING 4
121 INJECTION SITE BRUISING 4
122 INJECTION SITE PAIN 4
123 INJURY 4
124 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4
125 MIGRAINE 4
126 MOVEMENT DISORDER 4
127 MUSCULAR WEAKNESS 4
128 NERVE INJURY 4
129 PSORIASIS 4
130 RHEUMATOID ARTHRITIS 4
131 SKIN DISORDER 4
132 TREMOR 4
133 WOUND SECRETION 4
134 ACCIDENT 3
135 APPLICATION SITE IRRITATION 3
136 APPLICATION SITE REACTION 3
137 APPLICATION SITE SCAR 3
138 BLOOD PRESSURE INCREASED 3
139 BURN INFECTION 3
140 CHEST DISCOMFORT 3
141 CONFUSIONAL STATE 3
142 DEPRESSED MOOD 3
143 DEVICE ISSUE 3
144 DRUG ABUSE 3
145 DRUG ADMINISTERED AT INAPPROPRIATE SITE 3
146 DRUG DEPENDENCE 3
147 DRUG HYPERSENSITIVITY 3
148 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3
149 DYSGEUSIA 3
150 DYSPHONIA 3
151 EYE SWELLING 3
152 FLATULENCE 3
153 HAEMOPTYSIS 3
154 HEAD INJURY 3
155 HOT FLUSH 3
156 IMPAIRED HEALING 3
157 INCORRECT DRUG ADMINISTRATION DURATION 3
158 JOINT STIFFNESS 3
159 MEDICATION ERROR 3
160 MYOSITIS 3
161 NEOPLASM MALIGNANT 3
162 NEUROPATHY PERIPHERAL 3
163 PARAESTHESIA 3
164 PRODUCTIVE COUGH 3
165 RHINORRHOEA 3
166 SEIZURE 3
167 SEPSIS 3
168 SINUS DISORDER 3
169 SLEEP DISORDER 3
170 THERAPEUTIC RESPONSE SHORTENED 3
171 THERAPY CESSATION 3
172 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3
173 ABASIA 2
174 ACCIDENTAL EXPOSURE TO PRODUCT 2
175 ACTIVITIES OF DAILY LIVING IMPAIRED 2
176 ADMINISTRATION SITE PAIN 2
177 ADVERSE EVENT 2
178 ANAEMIA 2
179 APPLICATION SITE BRUISE 2
180 APPLICATION SITE HYPERSENSITIVITY 2
181 APPLICATION SITE RASH 2
182 ASTHMA 2
183 ATRIAL FIBRILLATION 2
184 BACK DISORDER 2
185 BACK INJURY 2
186 BACTERIAL TEST POSITIVE 2
187 BLOOD URINE PRESENT 2
188 BURNS FIRST DEGREE 2
189 CANDIDA INFECTION 2
190 CARDIAC DISORDER 2
191 CARDIAC FAILURE CONGESTIVE 2
192 CELLULITIS 2
193 CENTRAL NERVOUS SYSTEM LESION 2
194 CHONDROPATHY 2
195 CHRONIC KIDNEY DISEASE 2
196 COGNITIVE DISORDER 2
197 CROHN^S DISEASE 2
198 CYSTITIS 2
199 DEEP VEIN THROMBOSIS 2
200 DEHYDRATION 2
201 DEVICE DISLOCATION 2
202 DEVICE MAINTENANCE ISSUE 2
203 DISORIENTATION 2
204 DRUG DOSE OMISSION 2
205 DRY EYE 2
206 DRY MOUTH 2
207 EPISTAXIS 2
208 EYE DISORDER 2
209 FLUID RETENTION 2
210 FROSTBITE 2
211 FRUSTRATION TOLERANCE DECREASED 2
212 GASTRIC DISORDER 2
213 GENITAL BURNING SENSATION 2
214 HAEMORRHAGE 2
215 HALLUCINATION 2
216 HEART RATE INCREASED 2
217 HOSPITALISATION 2
218 HYPERHIDROSIS 2
219 HYPOACUSIS 2
220 ILLNESS 2
221 INCORRECT PRODUCT ADMINISTRATION DURATION 2
222 INCORRECT ROUTE OF DRUG ADMINISTRATION 2
223 INFLAMMATION 2
224 INFUSION SITE DISCOMFORT 2
225 INFUSION SITE INFLAMMATION 2
226 INFUSION SITE IRRITATION 2
227 INJECTION SITE ERYTHEMA 2
228 INJECTION SITE HAEMATOMA 2
229 INJECTION SITE HAEMORRHAGE 2
230 INSURANCE ISSUE 2
231 INTENTIONAL DOSE OMISSION 2
232 INTENTIONAL PRODUCT MISUSE 2
233 INTERNATIONAL NORMALISED RATIO DECREASED 2
234 JOINT EFFUSION 2
235 JOINT INJURY 2
236 LIP SWELLING 2
237 METASTASES TO BONE 2
238 MULTIPLE SCLEROSIS 2
239 MUSCLE STRAIN 2
240 MUSCULOSKELETAL DISCOMFORT 2
241 NASAL OEDEMA 2
242 NEOPLASM 2
243 NEPHROPATHY 2
244 OEDEMA 2
245 OROPHARYNGEAL PAIN 2
246 ORTHOSTATIC HYPOTENSION 2
247 PALPITATIONS 2
248 PERIPHERAL MOTOR NEUROPATHY 2
249 PHARYNGEAL OEDEMA 2
250 PHOTOPHOBIA 2
251 PLASMA CELL MYELOMA 2
252 POISONING 2
253 PRODUCT DOSE OMISSION 2
254 PRODUCT PHYSICAL ISSUE 2
255 PRODUCT SUBSTITUTION ISSUE 2
256 QUALITY OF LIFE DECREASED 2
257 RASH ERYTHEMATOUS 2
258 RASH MACULAR 2
259 RASH PAPULAR 2
260 RASH PRURITIC 2
261 RED BLOOD CELL COUNT DECREASED 2
262 RENAL DISORDER 2
263 RENAL IMPAIRMENT 2
264 RHEUMATIC FEVER 2
265 SECOND DEGREE CHEMICAL BURN OF SKIN 2
266 SINUSITIS 2
267 SKIN DEPIGMENTATION 2
268 SPEECH DISORDER 2
269 STEVENS-JOHNSON SYNDROME 2
270 SURGERY 2
271 SUSPECTED PRODUCT QUALITY ISSUE 2
272 TERMINAL STATE 2
273 THERAPEUTIC PRODUCT EFFECT DECREASED 2
274 THERAPEUTIC RESPONSE UNEXPECTED 2
275 THERAPY CHANGE 2
276 THERAPY NON-RESPONDER 2
277 THERAPY PARTIAL RESPONDER 2
278 THROMBOSIS 2
279 TOOTH FRACTURE 2
280 TOXICITY TO VARIOUS AGENTS 2
281 UNDERDOSE 2
282 UPPER RESPIRATORY TRACT INFECTION 2
283 URINARY INCONTINENCE 2
284 URINARY TRACT DISORDER 2
285 WHITE BLOOD CELL COUNT DECREASED 2
286 WOUND 2
287 WRONG PRODUCT ADMINISTERED 2
288 ABDOMINAL DISTENSION 1
289 ABDOMINAL PAIN UPPER 1
290 ABNORMAL BEHAVIOUR 1
291 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1
292 ACCIDENTAL OVERDOSE 1
293 ACNE 1
294 ADMINISTRATION SITE RASH 1
295 ADULT FAILURE TO THRIVE 1
296 ADVERSE DRUG REACTION 1
297 AFFECT LABILITY 1
298 AGEUSIA 1
299 AGGRESSION 1
300 AGITATION 1
301 ALLERGY TO PLANTS 1
302 ALVEOLAR OSTEITIS 1
303 ANGER 1
304 ANGIOEDEMA 1
305 ANKLE FRACTURE 1
306 ANOSMIA 1
307 ANTICOAGULANT THERAPY 1
308 APPLICATION SITE DRYNESS 1
309 APPLICATION SITE HAEMORRHAGE 1
310 APPLICATION SITE HYPOAESTHESIA 1
311 APPLICATION SITE INFECTION 1
312 APPLICATION SITE INFLAMMATION 1
313 APPLICATION SITE PUSTULES 1
314 APPLICATION SITE SCAB 1
315 APPLICATION SITE WARMTH 1
316 ARRHYTHMIA 1
317 ARTHROPATHY 1
318 ARTHROSCOPY 1
319 ASCITES 1
320 ASPIRATION 1
321 ATELECTASIS 1
322 ATRIOVENTRICULAR BLOCK 1
323 BACTERIAL ABDOMINAL INFECTION 1
324 BEDRIDDEN 1
325 BLADDER CANCER 1
326 BLADDER DISORDER 1
327 BLADDER ULCER 1
328 BLINDNESS 1
329 BLINDNESS TRANSIENT 1
330 BLOOD BILIRUBIN DECREASED 1
331 BLOOD BLISTER 1
332 BLOOD COUNT ABNORMAL 1
333 BLOOD CREATININE INCREASED 1
334 BLOOD GLUCOSE DECREASED 1
335 BLOOD GLUCOSE INCREASED 1
336 BLOOD IRON DECREASED 1
337 BLOOD IRON INCREASED 1
338 BLOOD LACTATE DEHYDROGENASE ABNORMAL 1
339 BLOOD PHOSPHORUS DECREASED 1
340 BLOOD POTASSIUM DECREASED 1
341 BLOOD PRESSURE ABNORMAL 1
342 BLOOD PRESSURE FLUCTUATION 1
343 BLOOD TRIGLYCERIDES INCREASED 1
344 BLOODY DISCHARGE 1
345 BONE CONTUSION 1
346 BONE DISORDER 1
347 BRADYCARDIA 1
348 BREAST SWELLING 1
349 BUNDLE BRANCH BLOCK RIGHT 1
350 BURNS FOURTH DEGREE 1
351 CARDIAC FAILURE 1
352 CARDIO-RESPIRATORY ARREST 1
353 CARTILAGE INJURY 1
354 CATARACT 1
355 CEREBRAL INFARCTION 1
356 CHILLS 1
357 CHOKING 1
358 CHONDROLYSIS 1
359 CHROMATURIA 1
360 CIRCULATORY COLLAPSE 1
361 COAGULOPATHY 1
362 COMPRESSION FRACTURE 1
363 CONCOMITANT DISEASE AGGRAVATED 1
364 CONTRAINDICATED PRODUCT ADMINISTERED 1
365 COUNTERFEIT PRODUCT ADMINISTERED 1
366 CRYING 1
367 CYANOSIS 1
368 CYSTITIS INTERSTITIAL 1
369 DEAFNESS 1
370 DECREASED ACTIVITY 1
371 DENTAL CARIES 1
372 DERMATITIS 1
373 DERMATITIS ACNEIFORM 1
374 DERMATITIS CONTACT 1
375 DERMATITIS EXFOLIATIVE 1
376 DEVICE ADHESION ISSUE 1
377 DEVICE ALARM ISSUE 1
378 DEVICE DEFECTIVE 1
379 DEVICE DIFFICULT TO USE 1
380 DEVICE EXPULSION 1
381 DEVICE FAILURE 1
382 DEVICE INFORMATION OUTPUT ISSUE 1
383 DEVICE INFUSION ISSUE 1
384 DEVICE MALFUNCTION 1
385 DEVICE POWER SOURCE ISSUE 1
386 DEVICE STIMULATION ISSUE 1
387 DISABILITY 1
388 DISEASE PROGRESSION 1
389 DRUG EFFECT DECREASED 1
390 DRUG EFFECT INCOMPLETE 1
391 DRUG SCREEN FALSE POSITIVE 1
392 DRUG SCREEN NEGATIVE 1
393 DRUG TOLERANCE DECREASED 1
394 DRUG TOXICITY 1
395 DRUG WITHDRAWAL SYNDROME 1
396 DRY SKIN 1
397 DUST ALLERGY 1
398 DYSPEPSIA 1
399 DYSPHAGIA 1
400 DYSPNOEA EXERTIONAL 1
401 DYSTONIA 1
402 DYSURIA 1
403 EAR PAIN 1
404 ECONOMIC PROBLEM 1
405 EMOTIONAL DISTRESS 1
406 ENTEROCOLITIS 1
407 ENURESIS 1
408 EPILEPSY 1
409 ESCHAR 1
410 EXPIRED DRUG ADMINISTERED 1
411 EXPOSURE DURING PREGNANCY 1
412 EXTRA DOSE ADMINISTERED 1
413 EYE INFLAMMATION 1
414 FAECES DISCOLOURED 1
415 FAECES HARD 1
416 FAILURE TO THRIVE 1
417 FEEDING DISORDER 1
418 FEELING OF BODY TEMPERATURE CHANGE 1
419 FINE MOTOR SKILL DYSFUNCTION 1
420 FOOT FRACTURE 1
421 FRUSTRATION 1
422 FUNCTIONAL GASTROINTESTINAL DISORDER 1
423 GAIT INABILITY 1
424 GALLBLADDER DISORDER 1
425 GASTRIC ULCER 1
426 GASTROINTESTINAL DISORDER 1
427 GASTROOESOPHAGEAL REFLUX DISEASE 1
428 GENERAL PHYSICAL HEALTH DETERIORATION 1
429 GENERAL SYMPTOM 1
430 GINGIVAL DISCOMFORT 1
431 GINGIVAL SWELLING 1
432 GINGIVITIS 1
433 GLOMERULAR FILTRATION RATE INCREASED 1
434 GLOSSITIS 1
435 GLOSSODYNIA 1
436 GRIP STRENGTH DECREASED 1
437 GYNAECOMASTIA 1
438 HAEMARTHROSIS 1
439 HAEMATOCHEZIA 1
440 HAEMOGLOBIN DECREASED 1
441 HAEMORRHAGE URINARY TRACT 1
442 HAEMORRHAGIC ANAEMIA 1
443 HEAD DISCOMFORT 1
444 HEART TRANSPLANT 1
445 HEPATOMEGALY 1
446 HIATUS HERNIA 1
447 HIP FRACTURE 1
448 HYPERKERATOSIS 1
449 HYPERPARATHYROIDISM SECONDARY 1
450 HYPERSOMNIA 1
451 HYPERTENSION 1
452 HYPERVIGILANCE 1
453 HYPERVOLAEMIA 1
454 HYPOGEUSIA 1
455 HYPOKALAEMIA 1
456 HYPOPHAGIA 1
457 HYPOSMIA 1
458 HYPOTHERMIA 1
459 IMMOBILE 1
460 IMPLANTABLE DEFIBRILLATOR INSERTION 1
461 INABILITY TO AFFORD MEDICATION 1
462 INADEQUATE ANALGESIA 1
463 INCISION SITE HAEMORRHAGE 1
464 INCORRECT DOSE ADMINISTERED 1
465 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1
466 INFECTIOUS MONONUCLEOSIS 1
467 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1
468 INFLUENZA A VIRUS TEST POSITIVE 1
469 INFUSION SITE INDURATION 1
470 INFUSION SITE INFECTION 1
471 INFUSION SITE OEDEMA 1
472 INFUSION SITE REACTION 1
473 INFUSION SITE WARMTH 1
474 INITIAL INSOMNIA 1
475 INJECTION SITE INDURATION 1
476 INJECTION SITE PRURITUS 1
477 INTENTIONAL OVERDOSE 1
478 INTENTIONAL PRODUCT MISUSE TO CHILD 1
479 INTERNAL HAEMORRHAGE 1
480 INTERNATIONAL NORMALISED RATIO INCREASED 1
481 INTERSTITIAL LUNG DISEASE 1
482 INTERVERTEBRAL DISC DEGENERATION 1
483 INTERVERTEBRAL DISC DISORDER 1
484 INTERVERTEBRAL DISC PROTRUSION 1
485 INTESTINAL FUNCTIONAL DISORDER 1
486 INTESTINAL OBSTRUCTION 1
487 INTRA-ABDOMINAL FLUID COLLECTION 1
488 INTRACRANIAL HAEMATOMA 1
489 IRON DEFICIENCY 1
490 IRRITABILITY 1
491 JAUNDICE 1
492 JAUNDICE NEONATAL 1
493 KELOID SCAR 1
494 KIDNEY INFECTION 1
495 KNEE ARTHROPLASTY 1
496 LACRIMATION INCREASED 1
497 LEFT VENTRICULAR HYPERTROPHY 1
498 LEG AMPUTATION 1
499 LETHARGY 1
500 LIMB CRUSHING INJURY 1
501 LIMB INJURY 1
502 LIMB MASS 1
503 LIP EXFOLIATION 1
504 LIVING IN RESIDENTIAL INSTITUTION 1
505 LOCAL SWELLING 1
506 LOCALISED INFECTION 1
507 LOWER GASTROINTESTINAL HAEMORRHAGE 1
508 LOWER LIMB FRACTURE 1
509 LUMBAR SPINAL STENOSIS 1
510 LUNG DISORDER 1
511 LUNG TRANSPLANT 1
512 LYMPHADENOPATHY 1
513 MALIGNANT NEOPLASM PROGRESSION 1
514 MANIA 1
515 MASS 1
516 MATERNAL DRUGS AFFECTING FOETUS 1
517 MEDICAL DEVICE SITE PAIN 1
518 MENTAL STATUS CHANGES 1
519 METASTASES TO LIVER 1
520 METASTASIS 1
521 MOOD SWINGS 1
522 MOTOR DYSFUNCTION 1
523 MULTI-ORGAN DISORDER 1
524 MULTIPLE INJURIES 1
525 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1
526 MUSCLE ATROPHY 1
527 MUSCLE DISORDER 1
528 MUSCLE HAEMORRHAGE 1
529 MUSCLE RIGIDITY 1
530 MUSCLE SPASTICITY 1
531 MUSCLE TIGHTNESS 1
532 MUSCULOSKELETAL CHEST PAIN 1
533 MUSCULOSKELETAL DISORDER 1
534 NASAL DISCOMFORT 1
535 NECK SURGERY 1
536 NEGATIVISM 1
537 NEPHROLITHIASIS 1
538 NERVE COMPRESSION 1
539 NEURALGIA 1
540 NEUTROPHIL COUNT ABNORMAL 1
541 NEUTROPHIL COUNT DECREASED 1
542 NIGHT SWEATS 1
543 NIGHTMARE 1
544 NIPPLE SWELLING 1
545 NODULE 1
546 NON-CARDIAC CHEST PAIN 1
547 OCULAR DISCOMFORT 1
548 OCULAR HYPERAEMIA 1
549 OESOPHAGEAL INFECTION 1
550 OFF LABEL USE OF DEVICE 1
551 ORAL DISORDER 1
552 ORAL MUCOSAL ERUPTION 1
553 ORCHIDECTOMY 1
554 OROPHARYNGEAL SWELLING 1
555 OSTEOMYELITIS 1
556 OVERDOSE 1
557 PAIN IN JAW 1
558 PANCREATIC CYST 1
559 PANCYTOPENIA 1
560 PANIC ATTACK 1
561 PANIC REACTION 1
562 PARALYSIS 1
563 PARANASAL SINUS HYPERSECRETION 1
564 PARANOIA 1
565 PARKINSON^S DISEASE 1
566 PATELLA FRACTURE 1
567 PATHOLOGICAL FRACTURE 1
568 PERICARDIAL EFFUSION 1
569 PERICARDITIS 1
570 PERONEAL NERVE PALSY 1
571 PHARMACEUTICAL PRODUCT COMPLAINT 1
572 PHARYNGITIS STREPTOCOCCAL 1
573 PLATELET COUNT ABNORMAL 1
574 PLATELET COUNT DECREASED 1
575 PNEUMONIA ASPIRATION 1
576 POLLAKIURIA 1
577 POOR PERIPHERAL CIRCULATION 1
578 POOR QUALITY PRODUCT ADMINISTERED 1
579 POST PROCEDURAL COMPLICATION 1
580 POST PROCEDURAL INFECTION 1
581 POST-ACUTE COVID-19 SYNDROME 1
582 POSTNASAL DRIP 1
583 PRESCRIBED OVERDOSE 1
584 PRODUCT ADMINISTRATION INTERRUPTED 1
585 PRODUCT CLOSURE ISSUE 1
586 PRODUCT CONTAMINATION MICROBIAL 1
587 PRODUCT LABEL ISSUE 1
588 PRODUCT LABEL ON WRONG PRODUCT 1
589 PRODUCT PACKAGE ASSOCIATED INJURY 1
590 PRODUCT PACKAGING QUANTITY ISSUE 1
591 PRODUCT SOLUBILITY ABNORMAL 1
592 PRODUCT TASTE ABNORMAL 1
593 PROSTATE CANCER 1
594 PROSTATE CANCER METASTATIC 1
595 PROSTATE INFECTION 1
596 PROSTATIC SPECIFIC ANTIGEN INCREASED 1
597 PSORIATIC ARTHROPATHY 1
598 PULMONARY EMBOLISM 1
599 PULMONARY HYPERTENSION 1
600 PULMONARY MASS 1
601 PULMONARY PAIN 1
602 PYELONEPHRITIS 1
603 RADICULOPATHY 1
604 RASH MACULO-PAPULAR 1
605 RECALLED PRODUCT ADMINISTERED 1
606 RECTAL DISCHARGE 1
607 RECTAL HAEMORRHAGE 1
608 RENAL CANCER 1
609 RENAL CYST 1
610 RENAL FAILURE 1
611 RENAL FAILURE ACUTE 1
612 RESPIRATORY TRACT INFECTION 1
613 RHABDOMYOLYSIS 1
614 RHONCHI 1
615 RIB FRACTURE 1
616 ROAD TRAFFIC ACCIDENT 1
617 ROTATOR CUFF SYNDROME 1
618 SCHIZOAFFECTIVE DISORDER 1
619 SCOLIOSIS 1
620 SEASONAL ALLERGY 1
621 SENSITIVE SKIN 1
622 SENSORY DISTURBANCE 1
623 SEPTIC SHOCK 1
624 SERUM FERRITIN DECREASED 1
625 SINGLE COMPONENT OF A TWO-COMPONENT PRODUCT ADMINISTERED 1
626 SINUS BRADYCARDIA 1
627 SKIN ABRASION 1
628 SKIN GRAFT 1
629 SKIN HAEMORRHAGE 1
630 SKIN HYPOPIGMENTATION 1
631 SKIN ODOUR ABNORMAL 1
632 SKIN ULCER 1
633 SKIN WARM 1
634 SLEEP DEFICIT 1
635 SLOW SPEECH 1
636 SPINAL DISORDER 1
637 SPUTUM DISCOLOURED 1
638 SQUAMOUS CELL CARCINOMA 1
639 STENOSIS 1
640 STREPTOCOCCAL INFECTION 1
641 SUDDEN DEATH 1
642 SUICIDAL IDEATION 1
643 SUSPECTED OFF LABEL USE 1
644 SWELLING FACE 1
645 SWOLLEN TONGUE 1
646 SYNCOPE 1
647 SYSTEMIC LUPUS ERYTHEMATOSUS 1
648 TACHYCARDIA 1
649 TASTE DISORDER 1
650 TEMPOROMANDIBULAR JOINT SYNDROME 1
651 TENDERNESS 1
652 TENDON DISORDER 1
653 TENDON PAIN 1
654 TENDONITIS 1
655 THERAPY INTERRUPTED 1
656 THIRD DEGREE CHEMICAL BURN OF SKIN 1
657 THROMBOCYTOPENIA 1
658 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 1
659 TOOTH DISORDER 1
660 TOOTHACHE 1
661 TOXIC EPIDERMAL NECROLYSIS 1
662 TRAUMATIC HAEMORRHAGE 1
663 TUBULOINTERSTITIAL NEPHRITIS 1
664 UNEVALUABLE EVENT 1
665 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1
666 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 1
667 URINARY BLADDER HAEMORRHAGE 1
668 URINARY RETENTION 1
669 URINE ODOUR ABNORMAL 1
670 URINE OUTPUT DECREASED 1
671 UVEITIS 1
672 VARICOSE VEIN 1
673 VASCULAR INSUFFICIENCY 1
674 VENTRICULAR SEPTAL DEFECT 1
675 VIRAL INFECTION 1
676 VISUAL IMPAIRMENT 1
677 VULVOVAGINAL BURNING SENSATION 1
678 WHEELCHAIR USER 1
679 WHEEZING 1
680 WHITE BLOOD CELL COUNT 1
681 WOUND HAEMORRHAGE 1
682 WOUND INFECTION 1